Friday, June 14, 2024
HomeNewsScandal of hope-filled Alzheimer’s therapy shelved to save Big Pharma’s profits 

Scandal of hope-filled Alzheimer’s therapy shelved to save Big Pharma’s profits 


ALZHEIMER’S is one of the plagues of modern ‘civilisation’. Anyone who has witnessed the hideous effects of the dementia condition on a beloved friend or relative will know that it is a fate worse than death.  

Slowly, by cruel degrees, you are turned into a zombie. It’s an appalling affliction for those who suffer from it. But it’s possibly even worse for the partners of those who have to live with it: The shell of their lifelong companion looking much the same as ever before, continually mocking them with the awareness of what they have lost. The light is still on, as they say, but inside there is nobody home. 

When death finally comes – usually in an expensive care home – it’s often a blessed relief. It shouldn’t be that way. No one wants to be put in a position where they are yearning for a loved one to die. But the burden, both financial and emotional, becomes insupportable.  

I’ll spare you the scatalogical horror of a relative’s experience when she had her Alzheimer’s husband home on day release. Suffice to say that when you hear stories like this, you start to understand the sentiment that leads people to consider Dignitas-style death clinics. 

Imagine, then, how wonderful it would be if someone were to find a cure for this dreadful condition! Or if, failing that, they at least were to discover its likely origins and find ways of both halting its advancement and preventing future cases. And imagine, better still, if it were capable of treating or alleviating a whole host of other conditions, from Parkinson’s to childhood autism. 

The pharmaceutical industry would be all over it. Doctors everywhere would be pushing for its immediate release. Insurance companies would be insisting on it for their older customers. The health pages of all the newspapers would be shouting to the rooftops about this massive, unprecedented breakthrough. Politicians would hail the miracle relief from a social and financial burden which, in the UK, costs the economy £34.7billion a year. The Alzheimer’s Society would soon be out of business. 

Or so you’d think, if you didn’t understand how the world works. But if you do, the story I’m about to tell will be wearisomely familiar. Yes, there is a possible cure, and near-certainly a preventative for Alzheimer’s (and those other conditions I mentioned). No, it is not easily available and little if anything is being done to change this, because there are too many vested interests at stake. 

The man who discovered the nature of the problem – and invented the solution – is Dr Boyd Haley, a retired chemistry professor who now lives on a ranch in the US state of Kentucky.  

In the 1980s, he began investigating the influence of metals on Alzheimer’s susceptibility. For years the suspected culprit was aluminium, from cooking pots and pans. But Haley’s laboratory research showed that one metal in particular caused a normal brain to develop the same biochemical abnormalities you find with Alzheimer’s – mercury. 

Instead of being feted for his discovery, however, Haley became something of a pariah. After 25 years, his federal research funding from the National Institutes of Health dried up. Nor was he invited to talk about his findings at any international Alzheimer’s conferences. Undeterred, he set about devising a solution: A substance that would bind to the mercury (and other heavy metals) in the body and safely remove them in a process known as ‘chelation.’ 

By 2005, his work was done. He had created a highly effective chelator which was non-toxic, even in large doses and which, being made purely of natural substances, meant it could be sold without regulation as a dietary substance rather than as a medicine.  

It was released on to the market a year later under the name NBMI (after its chemical formula). This was later changed to OSR, short for Oxidative Stress Relief, because that is what it does. It’s not the mercury by itself that does the damage, but rather the process – oxidisation – when it reacts with the iron in your body to form a toxic compound. 

OSR worked brilliantly. As well as being used with considerable success to treat Alzheimer’s patients (Haley has never claimed it can reverse the damage, only prevent any more happening), it also proved effective in treating Parkinson’s (one wheelchair-bound woman found herself able to walk and talk again) and also childhood autism, which Haley believes is triggered by the mercury used in vaccines to kill bacteria. 

But it was too successful for its own good. In 2010, OSR was shut down by the US Food and Drug Administration (FDA), which arbitrarily declared it to be a medicine and not a dietary supplement, and forbade its use until it had gone through a series of expensive and impossibly stringent trials. 

Twelve years on and Haley’s miracle solution – now renamed Emeramide – is still awaiting regulatory approval. Publicly, he remains optimistic. But I wonder whether this is just wishful thinking. Everything about his experiences so far suggests that the biomedical establishment will never allow Emeramide back on to the market because the political, financial and legal repercussions will be too damaging. 

For a start, it would put an end to the practice of amalgam fillings in dentistry. Many dentists still use them because they require less skill and because they can be put in at about twice the rate of white fillings. Both the official dental trade bodies in the US and the UK maintain that amalgams are perfectly safe and that they don’t leak mercury after they have been put in.  

Neither claim is true. But Haley believes the dental establishment would much rather maintain this position than admit the truth and expose the whole industry to endless lawsuits from disgruntled customers claiming, likely accurately, to have been caused neurological damage by their fillings. 

It would also kill a lucrative line in Big Pharma products. There are currently, in the US alone, an estimated 20million Alzheimer’s patients. By 2025, the global market for Alzheimer’s drugs is forecast to exceed 6.4billion dollars. Emeramide, if released, would bring that stellar growth rate to a halt – depriving the markets of the future victims it so badly needs to sustain its business model. 

This may be the reason why the biomedical establishment – which effectively owns the medical journals, the newspaper health columns, and the Alzheimer’s charities – rarely talks about the mercury issue. Instead, it prefers to focus on the amyloid plaques which have been fingered as the main cause of Alzheimer’s – a theory which has attracted billions of dollars worth of federal funding. But it recently emerged that the landmark study which advanced this thesis was fraudulent. And in any case, if Haley is correct, those plaques are merely another symptom of Alzheimer’s, not the actual cause. 

As for childhood autism, this is possibly an even bigger can of worms. In fact, this is the main reason Haley believes the FDA closed his product down. Mothers in autism chat groups were getting so vocal about the wonders it had wrought on their damaged children – especially with younger ones, whose debilitation was less advanced – that the secret about vaccine damage was in danger of getting too public.  

A bit like with Dr Andrew Wakefield, whose career was destroyed in the UK when he made similar connections, Dr Haley and his marvellous medicine had to be suppressed for the greater good of Big Pharma. 

If it hadn’t been for the shenanigans surrounding Covid, I might have called this the biggest scandal in medical history. Everything about the mercury issue stinks of graft, corruption and cover-up: The ongoing use of so damaging a substance, toxic even in small doses, in dental fillings and vaccines; the refusal by official bodies – from the American and British dental associations to Alzheimer’s and autism charities – to admit there is any connection; the deliberate and cynical suppression of a safe and genuinely effective treatment. 

And it’s not as if mercury toxicity is some wacko theory previously unknown to medical science and therefore deserving of extreme scepticism. The reason the Hatter in Alice’s Adventures in Wonderland is mad is because insanity was long an occupational hazard of the millinery industry. Why? Because mercury was used to stiffen the felt used to make hats. It has also been known for centuries that the old-fashioned treatment for syphilis – mercury – was worse than disease itself because it drove victims mad. 

Boyd Haley deserves a Nobel Prize for his efforts. Instead, he has been shunned and marginalised by the biomedical establishment and his treatment protocol, which could now be transforming the lives of millions of supposedly incurable Alzheimer’s, Parkinson’s and childhood autism victims, has been kicked into the long grass by malign vested interests. 

James Delingpole chats to Dr Boyd Haley on the Delingpod here, here and here

If you appreciated this article, perhaps you might consider making a donation to The Conservative Woman. Unlike most other websites, we receive no independent funding. Our editors are unpaid and work entirely voluntarily as do the majority of our contributors but there are inevitable costs associated with running a website. We depend on our readers to help us, either with regular or one-off payments. You can donate here. Thank you.
If you have not already signed up to a daily email alert of new articles please do so. It is here and free! Thank you.

James Delingpole
James Delingpole
James Delingpole is host of the Delingpod podcast. The Delingpod: The James Delingpole Podcast (

Sign up for TCW Daily

Each morning we send The ConWom Daily with links to our latest news. This is a free service and we will never share your details.